Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Kura Oncology (KURA) Accumulated Depreciation & Amortization (2023 - 2025)

Kura Oncology (KURA) has disclosed Accumulated Depreciation & Amortization for 3 consecutive years, with $3.7 million as the latest value for Q2 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization changed N/A to $3.7 million in Q2 2025 year-over-year; TTM through Jun 2025 was $3.7 million, a N/A change, with the full-year FY2024 number at $3.3 million, up 33.56% from a year prior.
  • Accumulated Depreciation & Amortization was $3.7 million for Q2 2025 at Kura Oncology, up from $3.3 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $3.7 million in Q2 2025 to a low of $1.8 million in Q1 2023.
  • A 3-year average of $2.8 million and a median of $2.9 million in 2024 define the central range for Accumulated Depreciation & Amortization.
  • Biggest YoY gain for Accumulated Depreciation & Amortization was 47.04% in 2024; the steepest drop was 33.56% in 2024.
  • Kura Oncology's Accumulated Depreciation & Amortization stood at $2.5 million in 2023, then soared by 33.56% to $3.3 million in 2024, then rose by 14.2% to $3.7 million in 2025.
  • Per Business Quant, the three most recent readings for KURA's Accumulated Depreciation & Amortization are $3.7 million (Q2 2025), $3.3 million (Q4 2024), and $3.1 million (Q3 2024).